Trial Profile

A Prospective Study Investigating the Seminal Tenofovir Concentrations, Viral Suppression and Semen Quality in HIV-1 Infected Men after Switching Antiretroviral Therapy from TDF/FTC/EVG/COBI to TAF/FTC/EVG/COBI (Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 24 Apr 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Apr 2018 New trial record
07 Mar 2018 Results presented at the 25th Conference on Retroviruses and Opportunistic Infections.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com